Christian Stenør

Dr. Christian Stenør

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2021 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
MJMette Syberg Jespersen
Mette Syberg Jespersen
SFSøren Fanø
Søren Fanø
CSChristian Stenør
Christian Stenør
AMAnne Kirstine Møller
Anne Kirstine Møller
Background: Immune checkpoint inhibitor (ICI)-related myocarditis is an uncommon but potentially fatal immune-related adverse event. Corticoid-resistant myocarditis induced by ICI is an important therapeutic challenge. Case summary: Here, we present a case of steroid-refractory ICI-related myocarditis and myositis treated with abatacept and mycophenolate mofetil (MMF). A 57-year-old male with metastatic renal cell carcinoma was diagnosed with immune-related myocarditis and myasthenia gravis-like myositis after first dose of combination ICIs with nivolumab (anti-programmed cell death-1) plus ipilimumab (anti-cytotoxic T-lymphocyte-associated antigen-4). Twelve days after ICI he was admitted to the hospital due to palpitations, headache, and pain in the extremities. Laboratory findings revealed elevated inflammatory markers and cardiac enzymes. Electrocardiogram showed first-degree atrioventricular (AV) block and right bundle branch block which developed into complete heart block within 48 h. Because of clinical and paraclinical deterioration despite immediate initiation of methylprednisolone abatacept and MMF was added. Following, gradual subjective improvement and termination of arrhythmia led to discharge of the patient from the hospital 6 weeks after the introduction of ICI. Discussion: The key treatment of ICI-related myocarditis is glucocorticoid. For steroid-refractory myocarditis supplementary immune suppressive agents are recommended. Yet, data still relies on case reports and case series, due to lack of prospective studies. In this case, the use of abatacept and MMF led to resolution of steroid-resistant ICI-related myocarditis and myositis.

9 July 2025 in European Journal of Neurology
Verified
Journal Article
Open access
ADAl‐Hasan Hussein Dos
Al‐Hasan Hussein Dos
NSNina Vindegaard Sørensen
Nina Vindegaard Sørensen
MSMalini Vendela Sagar
Malini Vendela Sagar
ALAnne‐Mette Lebech
Anne‐Mette Lebech
AHAnders Hougaard
Anders Hougaard
CSChristian Stenør
Christian Stenør
Introduction: Lyme neuroborreliosis (NB), is caused by tick‐borne spirochetes in the Borrelia burgdorferi sensu lato (Bbsl) genospecies complex. Although the clinical manifestations of NB in adults and children are well documented, understanding neurobiological differences between these groups can improve diagnostic accuracy and treatment approaches. This study aimed to characterize and compare the clinical presentation and cerebrospinal fluid (CSF) findings of NB in children and adults at the time of hospital admission.Methods: Retrospective analysis was performed of 3841 patients with an intrathecal Bbsl antibody index test performed at the Department of Microbiology at Herlev Hospital (Capital region of Denmark) between January 2016 and January 2024. Adults and children were included based on the European criteria for NB and compared for symptoms, such as peripheral facial palsy, and CSF variables, such as white blood cell (WBC) counts.Results: A total of 146 children and 267 adults were included. The annual incidence was 6.4 cases per 100 000 inhabitants. Median symptom duration before CSF analysis was 7 days for children and 21 days for adults. Facial palsy was the most common symptom in children (70%), whereas radicular pain predominated in adults (61%). CSF analysis showed significantly higher WBC counts in children vs. adults and significantly lower protein levels in children vs. adults, irrespective of symptom duration.Conclusion: There are substantial differences in the clinical presentation and CSF findings of NB between adults and children. NB incidence was much higher than previously reported in Denmark, underscoring the need for improved clinical awareness and early diagnosis.

13 October 2021 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
CSChristian Stenør
Christian Stenør
SMSahla El Mahdaoui
Sahla El Mahdaoui
NWNils Wolfram
Nils Wolfram

22 June 2025 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Open access
JBJulie Annida By
Julie Annida By
ADAl-Hasan Hussein Dos
Al-Hasan Hussein Dos
CSChristian Stenør
Christian Stenør
Tick-borne encephalitis (TBE) is a viral infection of the central nervous system (CNS) caused by the tick-borne encephalitis virus (TBEV). Currently, no specific antiviral treatment exists. Corticosteroids have been proposed as a potential immunomodulatory treatment in severe cases, but their role remains controversial. This case study describes a previously healthy 54-year-old male who developed biphasic TBE with initial improvement after high-dose dexamethasone, followed by clinical deterioration after steroid discontinuation. Neurological symptoms worsened, requiring intensive care, sedation, and mechanical ventilation. Subsequent treatment with high-dose methylprednisolone was associated with rapid clinical improvement. The patient's clinical course, along with CSF findings, supports an immunopathological mechanism, possibly mediated by T cells and cytokine-induced blood-brain barrier disruption. The case aligns with literature suggesting that corticosteroids may mitigate CNS inflammation in TBE, as seen in other neuroinflammatory infections. This case highlights the potential benefit of corticosteroids in TBE.

13 February 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
MØMathilde Ørbæk
Mathilde Ørbæk
MFMarie Fosbøl
Marie Fosbøl
AFAnna Maria Florescu
Anna Maria Florescu
CSChristian Stenør
Christian Stenør
MJMicha Phill Grønholm Jepsen
Micha Phill Grønholm Jepsen
ALAnne-Mette Lebech
Anne-Mette Lebech
Background: Macrophages play a key role in clearing Borrelia burgdorferi infection and express somatostatin receptor subtype 2 (SSTR2), a potential imaging target. This study investigates immune activation in neuroborreliosis (NB) and assesses the diagnostic value of 64Cu-DOTATATE positron emission tomography/computed tomography (PET/CT) alongside magnetic resonance imaging (MRI). Methods: Prospective cohort study (2024–2025) enrolling patients with suspected NB from four Danish hospitals. NB was defined by the following ≥2 criteria: neurological symptoms, cerebrospinal fluid (CSF) pleocytosis, and intrathecal B. burgdorferi-specific antibodies; patients not meeting these criteria served as controls. Results: The study included 20 participants: 15 NB patients (75%) and 5 controls (25%). PET/CT was performed after a median of 9.5 days of antibiotic treatment. Symmetric 64Cu-DOTATATE uptake in dorsal root and paravertebral ganglia was observed in 10 of 15 patients, with cervical involvement in 8 and lumbosacral in 9. All of them had symptoms that corresponded to the anatomical distribution of the uptake. No controls had lumbosacral involvement (p = 0.04). One control with erythema migrans and systemic symptoms showed cervical ganglia uptake. MRI showed cranial or spinal nerve enhancement in five patients. Only one patient had focal PET uptake matching MRI findings and clinical facial palsy. Conclusions: Symmetric 64Cu-DOTATATE ganglionic uptake in NB patients may reflect immune activation or altered ganglionic physiology. One patient had focal 64Cu-DOTATATE uptake corresponding with palsy and MRI and 64Cu-DOTATATE PET/CT did not contribute additional diagnostic value beyond standard clinical evaluation.

16 January 2026 in Journal of Neural Transmission
Verified
Journal Article
Open access
PDF file
ADAl-Hasan Hussein Dos
Al-Hasan Hussein Dos
AHAnders Hougaard
Anders Hougaard
RJRolf Munkholm Jensen
Rolf Munkholm Jensen
DSDavid Scheie
David Scheie
CSChristian Stenør
Christian Stenør
Central nervous system (CNS) vasculitis and stroke are rare manifestations of neuroborreliosis (NB). We aimed to describe the clinical course, paraclinical findings, treatments, and outcomes of patients with ischemic stroke and transient ischemic attack (TIA) associated with NB from a comprehensive patient cohort and compare these findings to existing literature. We retrospectively analyzed data from 3841 patients who underwent intrathecal Borrelia burgdorferi sensu lato antibody index testing at Herlev and Gentofte Hospital between 2016 and 2024. Patients who fulfilled the EFNS criteria for definite or possible NB and had clinical and/or radiological evidence of stroke or transient ischemic attack were included. In total, 413 patients fulfilled criteria for NB. Twelve adults and one child fulfilled our criteria for NB-associated stroke or TIA. Seven out of 13 patients presented with gait difficulty and 4/13 with upper motor neuron signs. Mean cerebrospinal fluid (CSF) glucose and CSF/blood glucose ratio were significantly lower compared to NB patients without cerebrovascular events in our cohort. Seven of 13 presented with cognitive symptoms prior to stroke. Twelve out of 13 had magnetic resonance imaging-verified brain infarctions. One patient died; autopsy confirmed lymphocytic vasculitis. High resolution vessel wall imaging, when performed ( n = 3), showed concentric vessel wall enhancement. Cerebrovascular manifestations of NB may present acutely with infarction or with chronic prodromal symptoms preceding stroke or transient ischemic attack. High resolution vessel wall imaging appears to be a promising noninvasive tool, potentially enabling earlier diagnosis and facilitating targeted treatment research.